Work

Regional Lymph Node Basin (RLNB) Relapse after Adjuvant Ipilimumab (Ipi) Anti-CTLA4 Immunotherapy in Stage III Melanoma: A Subgroup Analysis of a Randomized Placebo-Controlled Trial

Year: 2017

Type: article

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2017.06.193

Authors: C.A. Barker, K.A. Ahmed, J.J. Caudell, J.D. Schoenfeld, F.S. Hodi, D.B. Johnson, J.D. Wolchok

Institutions: Memorial Sloan Kettering Cancer Center, Moffitt Cancer Center, Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center, Vanderbilt University, Vanderbilt-Ingram Cancer Center

Language: English

Topic: Cutaneous Melanoma Detection and Management

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2760563623

FWCI: 0.121

Cites:

Cited by: 1

Related to: 10